COMMUNIQUÉS West-GlobeNewswire

SPINEWAY : Report de l’Assemblée Générale du 28 juin 2019
01/07/2019
Report de l’Assemblée Générale du 28 juin 2019 L'Assemblée Générale Ordinaire et Extraordinaire des actionnaires de Spineway, convoquée le 28 juin 2019 à 14 heures au siège social de la Société, n’a pas atteint le [...]
Novartis successfully completes acquisition of Xiidra®, bolstering ophthalmic portfolio
01/07/2019
Basel, July 1, 2019 - Novartis today announced that it has completed its acquisition of Xiidra® (lifitegrast ophthalmic solution) 5%, the first and only prescription treatment approved to treat both signs and symptoms [...]
Declaration of the number of shares and voting rights 06/2019
01/07/2019
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]
Déclaration d'actions et de droits de vote 06/2019
01/07/2019
DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions composant le capital (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) [...]
Asklepion Pharmaceuticals concludes enrollment of Phase III trial: L-citrulline for Prevention of Sequelae of Acute Lung Injury in Pediatrics Undergoing Cardiopulmonary Bypass for Heart Defects
01/07/2019
BALTIMORE, July 01, 2019 (GLOBE NEWSWIRE) -- Asklepion Pharmaceuticals, LLC (“Asklepion” or “the Company”), a biotechnology company focused on the development of novel therapeutics for rare pediatric diseases, today [...]
Transactions under Novozymes’ stock buyback program
01/07/2019
Please read the full announcement in the attached PDF Attachment 2019_21_Stock_Buybackprogram_EN
ClareMedica Health Partners and Beecken Petty O’Keefe & Company Form Partnership With Equity Investment
01/07/2019
CEO Roberto Palenzuela and Team Poised to Lead a Series of Florida-Based Primary Care Practice Acquisitions MIAMI, July 01, 2019 (GLOBE NEWSWIRE) -- ClareMedica Health Partners, LLC (“ClareMedica”) one of Florida’s [...]
The Joint Corp. Joins Russell 2000® and 3000® Indexes
01/07/2019
SCOTTSDALE, Ariz., July 01, 2019 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, will join the small-cap Russell 2000 ® Index and broad-market [...]
Becker’s Hospital Review Names North American Partners in Anesthesia (NAPA) a Top Place to Work in Healthcare for Fourth Consecutive Year
01/07/2019
MELVILLE, N.Y., July 01, 2019 (GLOBE NEWSWIRE) -- North American Partners in Anesthesia (NAPA), one of the leading single-specialty anesthesia and perioperative management companies in the US, is honored to be [...]
Managers' transactions
01/07/2019
Company Announcement No. 13 / 2019 For further information please contact: Martin Riise, Senior Director, Investor Relations, Tel: +45 5339 2250 Annika Stern, Investor Relations Officer, Tel: +45 2399 2382 Camilla [...]
Sanofi : Libtayo® (cemiplimab) approved for advanced cutaneous squamous cell carcinoma in the European Union
01/07/2019
Libtayo® (cemiplimab) approved for advanced cutaneous squamous cell carcinoma in the European Union Libtayo is the only treatment approved in the EU for adult patients with metastatic or locally advanced cutaneous [...]
Sanofi : Libtayo® (cemiplimab) approuvé dans l’Union européenne pour le traitement du carcinome épidermoïde cutané au stade avancé
01/07/2019
Libtayo® (cemiplimab) approuvé dans l’Union européenne pour le traitement du carcinome épidermoïde cutané au stade avancé Libtayo est le seul médicament approuvé dans l’UE pour le traitement du carcinome épidermoïde [...]
Coherus BioSciences Production Exceeds Four-Hundred Thousand UDENYCA® (pegfilgrastim-cbqv) Pre-Filled Syringes
01/07/2019
REDWOOD CITY, Calif., July 01, 2019 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or “the Company,” Nasdaq: CHRS), is pleased to announce that it has produced over 400,000 UDENYCA® pre-filled syringes to date [...]
OPKO Health’s BioReference Laboratories Forms a Strategic Collaboration With SOMOS to Improve Health Outcomes of Underserved New Yorkers
01/07/2019
SOMOS, New York City’s Largest Multi-Cultural Physician-Led Network, Selects BioReference as Preferred Provider for Diagnostic Testing BioReference to also assist with Patient-Centered Data Analytics to SOMOS Providers [...]
Krystal Biotech, Inc. Added to the Russell 2000 Index
01/07/2019
PITTSBURGH, July 01, 2019 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS), a gene therapy company developing medicines to treat skin diseases, today announces that it has been added to the Russell [...]
Y-mAbs Announces Recruitment Status for Pivotal Trials
01/07/2019
NEW YORK, July 01, 2019 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel [...]
Comprehensive Pharmacy Services Expands Senior Executive Team with Karl Bedwell
01/07/2019
Former Walmart Executive joins CPS as Chief Information Officer to support rapidly growing company MEMPHIS, Tenn., July 01, 2019 (GLOBE NEWSWIRE) -- Comprehensive Pharmacy Services (CPS), the nation’s largest hospital [...]
Cernostics Announces Formation of Distinguished Medical Advisory Board Including Top Specialists in All Facets of Esophageal Disease
01/07/2019
PITTSBURGH, PA, July 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Cernostics , developer of next-generation cancer diagnostics and prognostics, today announced the formation of a distinguished medical advisory board [...]
Seelos Therapeutics Added to Russell Microcap® Index
01/07/2019
NEW YORK, July 01, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (NASDAQ: SEEL), a clinical-stage biopharmaceutical company, announced today that it has been added to the Russell Microcap® Index, effective as of [...]

Pages